NOBOKIN is a nobel kinase inhibitor that decreases tumor cell proliferation. Main targets are receptor tyrosine kinase pathway such as VEGFR, PDGFR. FLT3, KIT, and RET pathway.
|Generic Name||Sorafenib Tosylate INN 200 mg|
|FDA Approved Indications||
|Packaging||NOBOKIN 200 mg tablets are supplied in alu-alu blister. Each commercial box of NOBOKIN contain 32’s (4X8’s) in alu-alu blister.|
|Prescribing Information||NOBOKIN (PDF)|